TITLE

Hepatitis B and liver cancer knowledge and practices among healthcare and public health professionals in China: a cross-sectional study

AUTHOR(S)
Chao, Jonathan; Chang, Ellen T.; So, Samuel K. S.
PUB. DATE
January 2010
SOURCE
BMC Public Health;2010, Vol. 10, p98
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Chronic hepatitis B virus (HBV) infection is the leading cause of liver disease and liver cancer and a major source of health-related discrimination in China. To better target HBV detection and prevention programs, it is necessary to assess existing HBV knowledge, educational resources, reporting, and preventive practices, particularly among those health professionals who would be responsible for implementing such programs. Methods: At the China National Conference on the Prevention and Control of Viral Hepatitis on April 26-29, 2004, the Asian Liver Center at Stanford University partnered with the China Foundation for Hepatitis Prevention and Control to distribute a voluntary written questionnaire to Chinese healthcare and public health professionals from regional and provincial Chinese Centers for Disease Control and Prevention, health departments, and medical centers. Correct responses to survey questions were summed into a total knowledge score, and multivariate linear regression was used to compare differences in the score by participant characteristics. Results: Although the median score was 81% correct, knowledge about HBV was inadequate, even among such highly trained health professionals. Of the 250 participants who completed the survey, 34% did not know that chronic HBV infection is often asymptomatic and 29% did not know that chronic HBV infection confers a high risk of cirrhosis, liver cancer, and premature death. Furthermore, 34% failed to recognize all the modes of HBV transmission and 30% did not know the importance of the hepatitis B vaccine in preventing liver disease. Respondents who reported poorer preventive practices, such as not having personally been tested for HBV and not routinely disposing of used medical needles, scored significantly lower in HBV knowledge than those who reported sound preventive practices. Of note, 38% of respondents reported positive HBsAg results to patients' employers and 25% reported positive results to patients' schools, thereby subjecting those with positive results to potential discriminatory practices. Conclusions: These results indicate that there is a need for development of effective educational programs to improve HBV knowledge among health professionals and the general public to avoid missed vaccination opportunities, reduce misconceptions, and eliminate discrimination based on chronic hepatitis B in China.
ACCESSION #
49160594

 

Related Articles

  • The B Positive Program as a model to reduce hepatitis B health disparities in high-risk communities in Australia. Fong, Gloria // Australian Medical Student Journal;2013, Vol. 4 Issue 2, p96 

    As the epicentre for the highest incidence of liver cancer diagnosis in New South Wales, southwest Sydney is simultaneously home to a large number of first generation migrants from Southeast Asia. Alarmingly, these individuals are six to twelve times more likely to be diagnosed with liver cancer...

  • The life-saving shot. Highfield, Roger // New Scientist;8/8/2009, Vol. 203 Issue 2720, p23 

    The article discusses the efficacy of vaccination in preventing deaths from hepatitis B and liver cancer. In China, a drop in prevalence of around 15%to fewer than 1% has been reported since the introduction of national vaccination programmes. However, the incidence of liver cancer in Taiwan...

  • Combating Hepatitis B: The Tripura Model. Bhaumik, Pradip; Choudhury, Ajit Ranjan; Sinha, Priyabrata // Euroasian Journal of Hepato-Gastroenterology;Jul-Dec2011, Vol. 1 Issue 2, p39 

    Although hepatitis B is a major public health problem globally, mass vaccination against this virus is yet to be implemented in many countries of the world, including in India, which happens to be one of the most populous nations in the globe. Hepatitis Foundation of Tripura has become a role...

  • Clustering of hepatitis B virus infection and hepatoceliular carcinoma in a family. Gilmore, I. T.; Harrison, J. M.; Parkins, R. A. // Journal of the Royal Society of Medicine;Nov1981, Vol. 74 Issue 11, p843 

    The article presents the results of the screening of a Chinese family following the death of one member who had been found to have hepatocellular carcinoma (HCC) associated with hepatitis B surface antigenaemia. There were four of the seven siblings traced. One had died of HCC five years...

  • Microfluidic platform for hepatitis B viral replication study. Sodunke, Temitope R.; Bouchard, Michael J.; Noh, Hongseok (Moses) // Biomedical Microdevices;Jun2008, Vol. 10 Issue 3, p393 

    Hepatocytes, the cells responsible for the metabolic and detoxification processes in the liver, are the predominant target of hepatitis B virus (HBV) infections, a major cause of liver cancer. The limited availability of normal human hepatocytes for cell-culture based studies is a significant...

  • HBV-Related Hepatocellular Carcinoma Susceptibility Gene KIF1B Is Not Associated with Development of Chronic Hepatitis B. Rong Zhong; Yao Tian; Li Liu; Qian Qiu; Ying Wang; Rui Rui; Bei-Fang Yang; Sheng-Yu Duan; Jun-Xin Shi; Xiao-Ping Miao; Li Wang; Hui Li // PLoS ONE;Feb2012, Vol. 7 Issue 2, p1 

    Background: A recent genome-wide association study has identified a new susceptibility locus, kinesin family member 1B gene (KIF1B), strongly associated with progression from chronic hepatitis B (CHB) to hepatitis B virus-related hepatocellular carcinoma (HCC) in Chinese population, this study...

  • Genetic polymorphism of glutathione S transferases M1 and T1 in Indian patients with hepatocellular carcinoma. Asim, Mohammad; Khan, Luqman A.; Husain, S. A.; Husain, Sajid; Sarma, Manash P.; Ahmad, Istaq; Sharma, J.K.; Sharma, Anita; Sharma, Shashi; Thayumanavan, L.; Kar, P. // Disease Markers;2010, Vol. 28 Issue 6, p369 

    Objective: Our aim was to evaluate whether the association of GSTM1/T1 gene polymorphisms modifies the risk of Hepatocellular carcinoma (HCC) and what is its correlation with other predisposing risk factors like alcohol intake, cigarette smoking and hepatitis B and C infections. Study...

  • Long-term outcome of chronic hepatitis B in Caucasian patients: mortality after 25 years. Fattovich, G.; Olivari, N.; Pasino, M.; D'Onofrio, M; Martone, E.; Donato, F. // Gut;Jan2008, Vol. 57 Issue 1, p84 

    Objective: To assess risk factors for liver-related death, we re-evaluated, after a median follow-up of 25 years, a cohort of 70 Caucasian patients with hepatitis B e antigen (HBeAg) positive chronic hepatitis (CH) at presentation. Methods: Follow-up studies included clinical and ultrasound...

  • HBV-Related Hepatocellular Carcinoma Susceptibility Gene KIF1B Is Not Associated with Development of Chronic Hepatitis B. Rong Zhong; Yao Tian; Li Liu; Qian Qiu; Ying Wang; Rui Rui; Bei-Fang Yang; Sheng-Yu Duan; Jun-Xin Shi; Xiao-Ping Miao; Li Wang; Hui Li // PLoS ONE;Feb2012, Vol. 7 Issue 2, p1 

    Background: A recent genome-wide association study has identified a new susceptibility locus, kinesin family member 1B gene (KIF1B), strongly associated with progression from chronic hepatitis B (CHB) to hepatitis B virus-related hepatocellular carcinoma (HCC) in Chinese population, this study...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics